SCHEDULE OF LOSS PER SHARE
| | |
2026 | | |
2025 | |
| | |
For
the six months ended March 31, | |
| | |
2026 (Unaudited) | | |
2025 (Unaudited) | |
| | |
USD’000 | | |
USD’000 | |
| Loss attributable to holders of ordinary shares
(USD’000): | |
| | | |
| | |
| Net loss | |
| (3,327 | ) | |
| (4,130 | ) |
| Weighted average number
of ordinary shares outstanding used in computing basic earnings per share * | |
| 3,726,200 | | |
| 2,440,920 | |
| Weighted
average number of ordinary shares outstanding used in computing diluted earnings per share * | |
| 3,726,200 | | |
| 2,440,920 | |
| Income (loss) per share - basic (USD) | |
| (0.89 | ) | |
| (1.69 | ) |
| Income (loss) per share - diluted (USD) ** | |
| (0.89 | ) | |
| (1.69 | ) |
| * |
The
number of shares reflected the one-for-six reverse split effective on March 5, 2026. |
| ** |
Warrants
to purchase Class A ordinary shares are not included in the diluted loss per share calculations when their effect is antidilutive.
For the six months ended March 31, 2026 and 2025, 175
shares and 209
shares, respectively, on a weighted
average basis of potential Class A ordinary shares related to outstanding Class A ordinary shares warrants were excluded from the
calculation of diluted net loss per share as such shares are antidilutive when there is a loss. |
|